John Zawad: Managing Director of Intellectual Property and
Vice Provost for Research Perry Molinoff announced last week that Dr. John Zawad has been appointed Managing Director of Intellectual Property and Technology Transfer, effective today. In this position, he will develop and implement a strategic plan for commercializing Penn’s technologies. He will help lead a streamlined technology transfer organization and lead a multi-year effort to create more significant royalty streams and valuable equity positions in enterprises created to commercialize Penn technology.
“We are fortunate that John Zawad is joining Penn in this position,” says Vice Provost Molinoff. “He is a respected and talented professional, and his commitment to technology transfer will greatly enhance our commercialization efforts. His experience in negotiating agreements with both companies and universities will bring an important skill to our program.”
Dr. Zawad brings to this position a combination of high scholarly qualifications and deep industry knowledge. He has been Vice President of Sanofi-Aventis Capital where he was responsible for managing an equity portfolio of 55 companies and the Genavent venture funds. Prior to that role, he was Vice President for Technology Licensing and Alliances at Sanofi-Aventis. At Sanofi-Aventis, Dr. Zawad successfully negotiated more than 50 agreements with pharmaceutical and biotechnology companies as well as with universities. He also has a background in scientific affairs and product development. His knowledge of the bio-medical industry, business experience, and wealth of professional relationships will make him an invaluable asset to the University.
“I am very excited about the opportunity to lead the Center for Technology Transfer and Penn’s commercialization efforts,” states Dr. Zawad. “I believe there is tremendous potential for creating added value for Penn through an active partnering program and the creation of new business ventures.”
Dr. Zawad earned a B.S. in chemistry from Memphis State University in 1975 and a Ph.D. in biochemistry from the University of Tennessee Center for the Health Sciences in 1983. In 1984, he was a post-doctoral fellow in pharmacology at Vanderbilt University. He is a member of several academic and professional organizations, including the Association of University Technology Managers and the Licensing Executives Society.
Almanac, Vol. 52, No. 10, November 1, 2005
November 1, 2005
Volume 52 Number 10